Although NKX3.1 transcriptional regulation certainly reduces its levels during PCa progression in some cases, there is a clear disagreement between NKX3.1 protein and mRNA levels in normal and PCa clinical tissues [30]. This evidence concerns the gene NKX3-1 and posterior cortical atrophy.